肝血管瘤

目的探讨肝血管瘤的螺旋CT新征象及其发生原因。

Objective To study the new signs of spiral CT ( SCT ) in the hepatic hemangioma ( HH ) and its causes .

目的：研究射频毁坏傅立叶采集稳态技术（RFFAST）的动态增强及延迟增强扫描MRI对肝血管瘤的诊断价值。

Objective : To study the value of dynamic enhanced MR imaging with RF FAST T_1WI in the diagnosis of hepatic hemangioma .

肝血管瘤螺旋CT新征象的初步研究

Primary Study of the New Signs of Spiral CT in Hepatic Hemangioma

肝血管瘤的螺旋CT三期扫描

Triple - phase spiral CT scanning in hepatic hemangiomas

肝血管瘤与肝癌非延迟CT扫描的鉴别诊断

Distinction between Hepatic Cavernous Hemangioma and Hepatocellular Carcinoma on Enhanced CT without Delayed Images

肝血管瘤周围灌注异常的MRI表现

The MRI appearance of hepatic perfusion disorder in hepatic hemangioma

81%的肝血管瘤和43%的肝癌增强结节呈周边分布，（P＜0.05）。

81 % of HCH and 43 % of HCC had globular and peripheral enhancement ( P < 0.05 ) .

肝血管瘤的血池效应与增强CT扫描比较有鉴别诊断意义。

To compare enhanced CT scan the " blood-pool effed " of hemangiona was very helpful in diagnosis .

方法本组30例行肝脏CT灌注扫描，其中肝血管瘤10例，肝囊肿3例；

Methods The30 routine liver CT perfusion scanning , 10 cases ofhepatic hemangioma , 3 cases of hepatic cysts ;

结论SENSE基础上扩散加权平面回波成像对肝癌（包括原发性肝癌和转移性肝癌）、肝血管瘤和肝囊肿的鉴别诊断具有较高的价值。

Conclusion : Diffusion-weighted imaging based on SENSE technology is useful in differentiation among hepatocarcinoma , hepatic metastases , hemangioma and cysts .

肝血管瘤合并动静脉瘘的DSA表现及介入治疗

Particular DSA Findings of Cavernous Hemangioma of the Liver Complicated with Arteriovenous Fistulas and the Interventional Therapy

结果：B超、CT、MRI诊断肝血管瘤的准确率分别为93%、91%及95%。

Results The accurate rates of BUS , CT and MRI in diagnosis for giant hemangioma of the liver were 93 % , 91 % and 95 % respectively .

低回声型肝血管瘤血流呈低速，阻力指数（RI）<0.6（60%）。

The blood flow of hypoechoic hepatic hemangioma appeared low velocity with RI less than 0.6 ( 60 % ) .

病灶染色在肝血管瘤CDE检查中的临床意义探讨

Study of Clinical Significance of " Focus Dye " in Hepatic Hemangioma with CDE

目的探讨血清总胆汁酸（TBA）测定对肝血管瘤肝功能评价的意义。

Objective To discuss the assessment significance of detection of serum total bile acid ( TAB ) in hepatic angioma .

RFA后肝血管瘤在大小、形态、密度及强化形态的变化上具有其特点。

Hepatic hemangioma has its characteristics in the transformation of size , shape , density and enhancement after RFA .

结论：RFA治疗肝血管瘤具有微创、有效、简单、安全和可重复等优点，选择合适的病例，肝血管瘤的RFA治疗是安全、有效的。

Conclusion : RFA for hepatic hemangioma was a mini-invasive , effective , simple , safe and repeatable method in selected patients .

而肝血管瘤患者血清中GPDA活性在正常范围（P>0.05）。

The activity of serum GPDA in hepatic angioma was normal ( P > 0.05 ) .

结论：肝脏血池SPECT对诊断肝血管瘤具有较高的灵敏度和特异性，可以用于鉴别肝脏占位性病变。

Conclusions : The liver blood pool SPECT is sensitive and specific in diagnosis of hepatic hemangiomas , and can be used to differentiate benign lesion from malignant lesion .

结果表明血清GPDA测定有助于肝癌与肝血管瘤之间的鉴别诊断。

Those data suggested that serum GPDA detection was helpful in differential diagnosis of hepatocarcinoma and hepato-hemangioma .

除此以外，AFP的增高还可见于别的疾病（如：恶性畸胎瘤、肝血管瘤、慢性肝炎、肝硬化等）。

In addition , the AFP heighten can also be seen in other disease ( such as : malignant teratoma , liver hemangioma , chronic hepatitis and liver cirrhosis , etc. ) .

肝血管瘤组病灶和非病灶各灌注参数的改变与HCC类似，但血管瘤病灶区的HBF较HCC大。

The differences of all parameters between lesion and non-lesion in hemangioma were similar to those in HCC , except for a higher HBF in lesion than in HCC .

36例肝血管瘤患者中有27例瘤体超过15cm，均按设计的手术入路与方式完成剥离切除手术。

Results Stripping resections of huge CHL with diameter exceeding 15 cm in 27 patients were successfully performed according to the designed operation route and mode .

目的：探讨抗癌抗生素平阳霉素碘油乳剂（PYM-Lip）栓塞硬化治疗肝血管瘤（CHL）的疗效。

Objective : To study the effect of embolization and sclerosis with antitumor antibiotic pingyangmycin ( PYM ) and lipiodol ( Lip ) emulsion in treatment of cavernous hemangioma of the liver ( CHL ) .

结果：28例肝血管瘤：肝血池3D立体图像确诊27例，平面图像确诊22例，断层图像确诊24例，均显示过度充填；27例TAC高峰左移，高度增加；

Results : Among 28 cases with hemangioma : 27 cases were diagnosed by 3D , 22 cases by plane , 24 cases by tomography , their hepatic blood pool were all filled , the spike of TAC shifting left with height increased ;

TAE治疗前，空腹血浆cAMP值在健康人、肝癌和肝血管瘤患者之间差异无显著性意义（P>0.05）。

Before TAE therapy , there was no significant difference among the plasma cAMP values ( measured 15 minutes after glucagon loading test ) of normal subjects , and of hepatic carcinoma and hepatic hemangioma cases ( P > 0.05 ) .

结论sonovue超声造影二次谐波成像技术能动态显示病灶增强特征，有助于肝血管瘤的准确诊断。

Conclusion the SonoVue contrast-enhanced ultrasound and second harmonic imaging can show dynamic enhancement features of liver hemangiomas , which is helpful to the accurate diagnosis .

结论：磁共振成像检查中，射频毁坏傅立叶采集稳态技术T1WI动态增强扫描能够显示肝血管瘤及邻近实质强化方式，与其他成像序列结合更有利于肝血管瘤的诊断。

Conclusion : Dynamic contrast-enhanced RF FAST T_1WI can display the enhancing pattern of hepatic hemangioma and the adjacent hepatic tissue . Combined with other scanning sequences , it will add to the confidence of the diagnosis of hepatic hemangioma .

肝血管瘤的增强峰值时间（65.0±24.6s）明显比其他肿瘤长（P<0.05）。

The time of peak enhancement ( 65.0 ± 24.6s ) in hemangiomas was obviously longer than that in other hepatic tumors ( P < 0.05 ) .

方法：选择56例FLL患者90个病灶行超声造影检查，包括：原发性肝癌24个，转移性肝癌43个，肝血管瘤19个，肝局部脂肪缺失3个和肝脏结核坏死灶1个。

Methods Contrast-enhanced ultrasound were performed on 56 patients , with 90 focal liver lesions , including 24 primary liver cancers , 43 metastatic liver tumors , 19 hepatic hemangiomas , 3 focal fatty sparing of liver , and 1 liver tuberculosis necrotic lesion .